MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
Nuvectis Pharma Inc. (NASDAQ: NVCT)*
Organization & Developments: Nuvectis Pharma
Parents
Nuvectis Pharma Inc. (NASDAQ: NVCT)*
Children
*Nuvectis Pharma, Inc. (NVCT) is a preclinical stage biopharmaceutical company building a pipeline of therapies utilizing innovative precision targeting for serious conditions with unmet needs in oncology.
*The Company is initially focused on two programs - Heat Shock Factor 1 (HSF1) pathway inhibitor, discovered and developed in the drug discovery program at the Institute for Cancer Research (ICR) in London, England and SRC/YES1 kinase inhibitor from the University of Edinburgh, Scotland, U.K. (UoE).
2021: Nuvectis Pharma: Developing Precision Targeted Therapies In Oncology
2025: Nuvectis: Additional Data In Q2 Of 2025 Could Allow It To Stage A Comeback
Jumps
Finance & Acquisitions: Nuvectis Pharma
Key People: Nuvectis Pharma